Dynavax Technologies
DVAX
#4889
Rank
ยฃ1.36 B
Marketcap
ยฃ11.64
Share price
1.75%
Change (1 day)
13.84%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: ยฃ1.36 Billion

As of January 2026 Dynavax Technologies has a market cap of ยฃ1.36 Billion. This makes Dynavax Technologies the world's 4889th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.36 B1.93%
2025ยฃ1.34 B-1.52%
2024ยฃ1.36 B-3.99%
2023ยฃ1.41 B26.41%
2022ยฃ1.12 B-10.26%
2021ยฃ1.25 B247.56%
2020ยฃ0.35 B-1.67%
2019ยฃ0.36 B-19.26%
2018ยฃ0.45 B-45.95%
2017ยฃ0.83 B579.8%
2016ยฃ0.12 B-80.32%
2015ยฃ0.62 B120.02%
2014ยฃ0.28 B-8.77%
2013ยฃ0.31 B-3.12%
2012ยฃ0.32 B18.99%
2011ยฃ0.27 B13.02%
2010ยฃ0.23 B403.15%
2009ยฃ47.63 M108.52%
2008ยฃ22.84 M-77.67%
2007ยฃ0.10 B-45.05%
2006ยฃ0.18 B222.05%
2005ยฃ57.79 M-41.41%
2004ยฃ98.65 M

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Dynavax Technologies was reported to be:

ยฃ1.36 Billion
by Nasdaq info icon info icon
ยฃ1.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
ยฃ0.10 B-92.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ20.21 B 1,379.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ202.46 B 14,712.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ112.92 B 8,162.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ215.51 B 15,667.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ75.60 B 5,431.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ106.66 B 7,703.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ27.92 B 1,943.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ130.13 B 9,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA